These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29922267)

  • 1. An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia.
    Mansour AA; Banik S; Suresh RV; Kaur H; Malik M; McCormick AA; Bakshi CS
    Front Microbiol; 2018; 9():1195. PubMed ID: 29922267
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.
    Banik S; Mansour AA; Suresh RV; Wykoff-Clary S; Malik M; McCormick AA; Bakshi CS
    PLoS One; 2015; 10(6):e0130858. PubMed ID: 26098553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    McCormick AA; Shakeel A; Yi C; Kaur H; Mansour AM; Bakshi CS
    PLoS One; 2018; 13(4):e0194614. PubMed ID: 29684046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.
    Ashtekar AR; Katz J; Xu Q; Michalek SM
    PLoS One; 2012; 7(11):e50460. PubMed ID: 23209745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
    Mahawar M; Rabadi SM; Banik S; Catlett SV; Metzger DW; Malik M; Bakshi CS
    PLoS One; 2013; 8(4):e61539. PubMed ID: 23613871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
    Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
    Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
    Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
    Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of protective immunity against
    Zhao M; Zhai Y; Zai X; Mao Y; Hu E; Wei Z; Li Y; Li K; Liu Y; Xu J; Yu R; Chen W
    Front Cell Infect Microbiol; 2023; 13():1195314. PubMed ID: 37305410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.
    Alqahtani M; Ma Z; Fantone K; Malik M; Bakshi CS
    Infect Immun; 2021 Jun; 89(7):e0013421. PubMed ID: 33875472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical testing of a vaccine candidate against tularemia.
    Suresh RV; Ma Z; Sunagar R; Bhatty V; Banik S; Catlett SV; Gosselin EJ; Malik M; Bakshi CS
    PLoS One; 2015; 10(4):e0124326. PubMed ID: 25897786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.
    Kaur R; Chen S; Arévalo MT; Xu Q; Chen Y; Zeng M
    Clin Vaccine Immunol; 2012 Mar; 19(3):359-64. PubMed ID: 22278325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
    Jia Q; Bowen R; Dillon BJ; Masleša-Galić S; Chang BT; Kaidi AC; Horwitz MA
    Sci Rep; 2018 May; 8(1):7009. PubMed ID: 29725025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
    Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
    Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
    Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.